U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07092358) titled 'Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta' on July 13.
Brief Summary: The goal of this observational study is to explore the clinical and genetic characteristics, multi-omics profiles, disease mechanisms, biomarkers, and potential therapeutic targets of hereditary ataxia (HA) in patients diagnosed with HA, primarily in the Yangtze River Delta region of China. The main questions it aims to answer are:
* What are the key pathogenic genetic variants, modifying factors and special inheritance patterns underlying HA?
* How do multi-omics profiles correlate with clinical phenotypes, diseas...